• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿 XII 因子缺乏症行体外循环。

Cardiopulmonary bypass in a pediatric patient with factor XII deficiency.

机构信息

Children's Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.

出版信息

J Extra Corpor Technol. 2024 Sep;56(3):125-127. doi: 10.1051/ject/2024021. Epub 2024 Sep 20.

DOI:10.1051/ject/2024021
PMID:39303135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415032/
Abstract

The safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complications in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in factor XII deficient patients, however, documentation of successful monitoring during CPB is infrequent. With the use of the Hemochron Signature Elite and ACT + cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions for factor XII deficiency management with CPB.

摘要

体外循环(CPB)的安全使用依赖于给药、监测和逆转抗凝的能力。尽管很少见,但由于监测抗凝时出现的并发症,因子 XII 缺乏症患者给灌注师带来了挑战。已经提出了一些策略来帮助监测因子 XII 缺乏症患者的抗凝,但在 CPB 期间成功监测的记录很少。使用 Hemochron Signature Elite 和 ACT+ 试剂盒,对一名因子 XII 缺乏的 8 个月大的婴儿进行 CPB,抗凝监测可预测且可靠。本病例报告探讨了 CPB 中因子 XII 缺乏症管理的当前建议。

相似文献

1
Cardiopulmonary bypass in a pediatric patient with factor XII deficiency.小儿 XII 因子缺乏症行体外循环。
J Extra Corpor Technol. 2024 Sep;56(3):125-127. doi: 10.1051/ject/2024021. Epub 2024 Sep 20.
2
Cardiopulmonary Bypass in a Patient with Factor XII Deficiency.一名患有因子Ⅻ缺乏症患者的体外循环。
J Extra Corpor Technol. 2014 Sep;46(3):251-3.
3
Factor XII deficiency and cardiopulmonary bypass.因子 XII 缺乏与体外循环
Perfusion. 1995;10(1):13-6. doi: 10.1177/026765919501000103.
4
Factor XII Deficiency and Cardiopulmonary Bypass.凝血因子 XII 缺乏与体外循环
J Extra Corpor Technol. 2014 Sep;46(3):254-7.
5
Cardiopulmonary bypass in a child with severe Factor XII deficiency.一名患有严重因子XII缺乏症儿童的体外循环。
Perfusion. 2022 Apr;37(3):316-320. doi: 10.1177/0267659121999305. Epub 2021 Mar 5.
6
The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration for Cardiopulmonary Bypass in Severe Factor XII Deficiency.严重凝血因子 XII 缺乏症患者体外循环肝素抗凝时即时凝血检测系统(标准版)监测点 ACT+检测的应用
J Cardiothorac Vasc Anesth. 2022 Jul;36(7):2031-2034. doi: 10.1053/j.jvca.2021.05.021. Epub 2021 May 18.
7
Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation.凝血因子 XII 缺乏与体外循环:使用活化凝血时间的一种新型改良方法监测抗凝。
Anesthesiology. 1997 Oct;87(4):990-2. doi: 10.1097/00000542-199710000-00038.
8
Perioperative management of cardiac surgery patients with factor XII deficiency - two case reports.XII 因子缺乏的心脏手术患者围手术期管理——两例报告
Anaesthesiol Intensive Ther. 2012 Oct-Dec;44(4):217-20.
9
Implications for cardiac surgery in patients with factor XII deficiency.因子 XII 缺乏症患者心脏手术的意义。
Ann Thorac Surg. 2010 Feb;89(2):625-6. doi: 10.1016/j.athoracsur.2009.07.042.
10
Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.心脏手术中即时凝血时间的床边测量:Hemochron signature elite 和 Abbott i-STAT 的比较:一致性、符合率和临床可靠性。
BMC Anesthesiol. 2019 Sep 6;19(1):174. doi: 10.1186/s12871-019-0846-z.

本文引用的文献

1
The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration for Cardiopulmonary Bypass in Severe Factor XII Deficiency.严重凝血因子 XII 缺乏症患者体外循环肝素抗凝时即时凝血检测系统(标准版)监测点 ACT+检测的应用
J Cardiothorac Vasc Anesth. 2022 Jul;36(7):2031-2034. doi: 10.1053/j.jvca.2021.05.021. Epub 2021 May 18.
2
Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications.凝血因子 XII(哈格曼因子)缺乏症:危及生命并发症的罕见先兆。
Pan Afr Med J. 2019 May 21;33:39. doi: 10.11604/pamj.2019.33.39.18117. eCollection 2019.
3
The activated clotting time in cardiac surgery: should Celite or kaolin be used?
心脏手术中的活化凝血时间:应使用硅藻土还是高岭土?
Interact Cardiovasc Thorac Surg. 2017 Apr 1;24(4):549-554. doi: 10.1093/icvts/ivw435.
4
Neonatal Hemostatic Disorders: Issues and Challenges.新生儿止血障碍:问题与挑战
Semin Thromb Hemost. 2016 Oct;42(7):741-751. doi: 10.1055/s-0036-1593415. Epub 2016 Oct 5.
5
Factor XII Deficiency and Cardiopulmonary Bypass.凝血因子 XII 缺乏与体外循环
J Extra Corpor Technol. 2014 Sep;46(3):254-7.
6
Cardiopulmonary Bypass in a Patient with Factor XII Deficiency.一名患有因子Ⅻ缺乏症患者的体外循环。
J Extra Corpor Technol. 2014 Sep;46(3):251-3.
7
Hageman factor, platelets and polyphosphates: early history and recent connection. Hageman 因子、血小板和多聚磷酸盐:早期历史与近期关联。
J Thromb Haemost. 2010 Aug;8(8):1670-4. doi: 10.1111/j.1538-7836.2010.03893.x. Epub 2010 Apr 30.
8
Implications for cardiac surgery in patients with factor XII deficiency.因子 XII 缺乏症患者心脏手术的意义。
Ann Thorac Surg. 2010 Feb;89(2):625-6. doi: 10.1016/j.athoracsur.2009.07.042.
9
The elusive physiologic role of Factor XII.因子 XII 难以捉摸的生理作用。
J Clin Invest. 2008 Sep;118(9):3006-9. doi: 10.1172/JCI36617.
10
Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation.凝血因子 XII 缺乏与体外循环:使用活化凝血时间的一种新型改良方法监测抗凝。
Anesthesiology. 1997 Oct;87(4):990-2. doi: 10.1097/00000542-199710000-00038.